TALPHERA, INC. Increase Decrease In Operating Lease Liability
TALPHERA, INC. (TLPH) reported Increase Decrease In Operating Lease Liability of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2025-03-31
- TALPHERA, INC. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- TALPHERA, INC. increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- TALPHERA, INC. increase decrease in operating lease liability for the quarter ending 2024-06-30 was $0.00.
- TALPHERA, INC. increase decrease in operating lease liability for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. increase decrease in operating lease liability for fiscal 2024 was $0.00.
- TALPHERA, INC. increase decrease in operating lease liability for fiscal 2023 was -$147.00K.
- TALPHERA, INC. increase decrease in operating lease liability for fiscal 2022 was -$285.00K.
- TALPHERA, INC. increase decrease in operating lease liability for fiscal 2020 was -$886.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | -$1.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | -$1.00K derived: sum of 3 quarters · filed 2025-03-31 | -$1.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | -$1.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.00K derived: sum of 3 quarters · filed 2025-03-31 | -$177.00K derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.00K derived: sum of 2 quarters · filed 2025-03-31 | -$177.00K derived: sum of 3 quarters · filed 2025-03-31 | -$147.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$176.00K derived: sum of 2 quarters · filed 2024-11-13 | -$146.00K 10-Q · filed 2024-11-13 | -$74.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$146.00K 10-Q · filed 2024-08-14 | -$74.00K derived: sum of 3 quarters · filed 2024-08-14 | -$29.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-14 | $102.00K derived: sum of 2 quarters · filed 2024-05-14 | $147.00K derived: sum of 3 quarters · filed 2024-05-14 | -$199.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $117.00K derived: sum of 2 quarters · filed 2024-03-06 | -$229.00K derived: sum of 3 quarters · filed 2024-03-06 | -$285.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$301.00K derived: sum of 2 quarters · filed 2023-11-14 | -$357.00K 10-Q · filed 2023-11-14 | -$245.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$402.00K 10-Q · filed 2023-08-10 | -$290.00K derived: sum of 3 quarters · filed 2023-08-10 | -$286.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$56.00K 10-Q · filed 2023-05-10 | $56.00K derived: sum of 2 quarters · filed 2023-08-01 | $60.00K derived: sum of 3 quarters · filed 2023-08-01 | -$262.00K derived: sum of 4 quarters · filed 2023-08-01 |
| 2021-12-31 | $112.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | $116.00K derived: sum of 2 quarters · filed 2023-08-01 | -$206.00K derived: sum of 3 quarters · filed 2023-08-01 | -$447.00K 8-K · filed 2023-08-01 |
| 2021-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$318.00K derived: sum of 2 quarters · filed 2022-11-14 | -$559.00K 10-Q · filed 2022-11-14 | -$772.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$563.00K 10-Q · filed 2022-08-11 | -$776.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$241.00K 10-Q · filed 2022-05-16 | -$454.00K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$886.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$673.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |